---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-034428"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-07-23T21:00:13+00:00"
generated_at: "2026-07-23T21:02:12.671504+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions resolves all cybersecurity review items for FDA 510(k) submission; on track for H2 2026 filing

## Summary
- Completed independent third-party penetration testing; all cybersecurity review items resolved.
- 100% of medium-risk vulnerabilities remediated; low-risk reduced from 11 to 2 with risk-based justification.
- All 19 software bill of materials (SBOM) vulnerabilities fully resolved; documentation aligned with FDA guidance.
- 510(k) submission targeting codeine detection as initial indication; planned U.S. market entry in multi-billion-dollar drug screening market.
- Manufacturing partnership with Syrma Johari MedTech expected to deliver >40% production cost savings and ~20 ppt gross margin improvement.

## SEC filing metadata
- accession: 0001493152-26-034428
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-07-23T21:00:13+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226034428/0001493152-26-034428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226034428/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-034428
- JSON: https://secwatch.observer/filing/0001493152-26-034428.json
- Plain text: https://secwatch.observer/filing/0001493152-26-034428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.